BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8501549)

  • 1. Review of studies evaluating ductal patency in the premature infant.
    Reller MD; Rice MJ; McDonald RW
    J Pediatr; 1993 Jun; 122(6):S59-62. PubMed ID: 8501549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The timing of spontaneous closure of the ductus arteriosus in infants with respiratory distress syndrome.
    Reller MD; Colasurdo MA; Rice MJ; McDonald RW
    Am J Cardiol; 1990 Jul; 66(1):75-8. PubMed ID: 2360535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal patency in neonates with respiratory distress syndrome. A randomized surfactant trial.
    Reller MD; Buffkin DC; Colasurdo MA; Rice MJ; McDonald RW
    Am J Dis Child; 1991 Sep; 145(9):1017-20. PubMed ID: 1877559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent ductus arteriosus and respiratory outcome in premature infants.
    Bancalari E; Claure N; Gonzalez A
    Biol Neonate; 2005; 88(3):192-201. PubMed ID: 16210841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant.
    Shimada S; Kasai T; Konishi M; Fujiwara T
    J Pediatr; 1994 Aug; 125(2):270-7. PubMed ID: 8040777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy.
    Heldt GP; Pesonen E; Merritt TA; Elias W; Sahn DJ
    Pediatr Res; 1989 Mar; 25(3):305-10. PubMed ID: 2649864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.
    Heyman E; Morag I; Batash D; Keidar R; Baram S; Berkovitch M
    Pediatrics; 2003 Nov; 112(5):e354. PubMed ID: 14595076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early functional closure of the ductus arteriosus associated with decreased severity of respiratory distress syndrome in preterm infants.
    Thibeault DW; Emmanouilides GC; Dodge ME; Lachman RS
    Am J Dis Child; 1977 Jul; 131(7):741-5. PubMed ID: 577658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation.
    Stefano JL; Abbasi S; Pearlman SA; Spear ML; Esterly KL; Bhutani VK
    Am Rev Respir Dis; 1991 Feb; 143(2):236-9. PubMed ID: 1990934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital heart disease and respiratory distress syndrome. Reversal of indomethacin closure of patent ductus arteriosus by prostaglandin therapy in a preterm infant.
    Strauss A; Modanlou HD; Gyepes M; Wittner R
    Am J Dis Child; 1982 Oct; 136(10):934-6. PubMed ID: 6889810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical features of patent ductus arteriosus in low-birthweight infants: a prospective analysis of 150 consecutively born infants.
    Siassi B; Blanco C; Cabal LA; Coran AG
    Pediatrics; 1976 Mar; 57(3):347-51. PubMed ID: 1256945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome.
    Shimada S; Kasai T; Hoshi A; Murata A; Chida S
    Pediatr Int; 2003 Jun; 45(3):255-62. PubMed ID: 12828577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the time of closure of the ductus arteriosus in severely ill premature infants.
    McKone RC; Weesner KM
    Clin Pediatr (Phila); 1988 Mar; 27(3):135-9. PubMed ID: 3342596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of assisted ventilation on echocardiographic findings in two infants with patent ductus arteriosus.
    Purohit DM; Caldwell CC; Webb HN; Levkoff AH
    J Thorac Cardiovasc Surg; 1976 Aug; 72(2):294-5. PubMed ID: 957745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent ductus arteriosus in neonates with severe respiratory disease.
    Dudell GG; Gersony WM
    J Pediatr; 1984 Jun; 104(6):915-20. PubMed ID: 6726527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating prostaglandin E2 concentrations and incidence of patent ductus arteriosus in preterm infants with respiratory distress syndrome.
    Clyman RI; Brett C; Mauray F
    Pediatrics; 1980 Nov; 66(5):725-9. PubMed ID: 7432878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.